Sun Pharmaceutical Industries Ltd releases Consolidated Financial Results for December 31, 2022.
Financial Results (Q3 FY2023) – Quarter-over-Quarter Comparison:
Total income of Sun Pharmaceutical Industries Ltd is Rs.11414.85 Crores (December 31, 2022) vs. Rs.11037.5 Crores (September 30, 2022)
Net profit/loss: Rs.2166.01 Crores (December 31, 2022) vs. Rs.2262.22 Crores (September 30, 2022)
EPS: Rs.9 (December 31, 2022) vs. Rs.9.4 (September 30, 2022)
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹11414.85 Cr | ₹11037.5 Cr | ⬆ 3.42% |
| Net Profit | ₹2166.01 Cr | ₹2262.22 Cr | ⬇ -4.25% |
| EPS | ₹9 | ₹9.4 | ⬇ -4.26% |
Financial Results (Q3 FY2023) – Year-over-Year Comparison:
Total income of Sun Pharmaceutical Industries Ltd is Rs.11414.85 Crores (December 31, 2022) vs. Rs.10295.57 Crores (December 31, 2022)
Net profit/loss: Rs.2166.01 Crores (December 31, 2022) vs. Rs.2058.80 Crores (December 31, 2022)
EPS: Rs.9 (December 31, 2022) vs. Rs.8.6 (December 31, 2022)
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹11414.85 Cr | ₹10295.57 Cr | ⬆ 10.87% |
| Net Profit | ₹2166.01 Cr | ₹2058.80 Cr | ⬆ 5.21% |
| EPS | ₹9 | ₹8.6 | ⬆ 4.65% |
Financial Results (9 Months Ended FY2023) – Year-over-Year Comparison:
Total income of Sun Pharmaceutical Industries Ltd is Rs.33216.25 Crores (December 31, 2022) vs. Rs.30015.65 Crores (December 31, 2021)
Net profit/loss: Rs.6489.11 Crores (December 31, 2022) vs. Rs.5549.98 Crores (December 31, 2021)
EPS: Rs.27 (December 31, 2022) vs. Rs.23.1 (December 31, 2021)
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹33216.25 Cr | ₹30015.65 Cr | ⬆ 10.66% |
| Net Profit | ₹6489.11 Cr | ₹5549.98 Cr | ⬆ 16.92% |
| EPS | ₹27 | ₹23.1 | ⬆ 16.88% |
For More Latest News Click Here
